stoxline Quote Chart Rank Option Currency Glossary
  
(LYEL)
  0 (0%)    07-18 22:20
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2025-07-18 4:42:46 PM
Short term     
Mid term     
Targets 6-month :  11.68 1-year :  12.8
Resists First :  10 Second :  10.96
Pivot price 9.43
Supports First :  8.46 Second :  7.03
MAs MA(5) :  9.41 MA(20) :  9.36
MA(100) :  9.99 MA(250) :  16.47
MACD MACD :  -0.1 Signal :  0
%K %D K(14,3) :  49.7 D(3) :  49
RSI RSI(14): 47.6
52-week High :  34.9 Low :  0.56
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ LYEL ] has closed above bottom band by 35.5%. Bollinger Bands are 63.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 9.77 - 9.83 9.83 - 9.89
Low: 9.09 - 9.15 9.15 - 9.21
Close: 9.13 - 9.23 9.23 - 9.34
Company Description

Headline News

Fri, 18 Jul 2025
What analysts say about LYEL stock - Rapid wealth creation - Jammu Links News

Mon, 23 Jun 2025
Lyell's Dual-Target CAR T-Cell Therapy Shows Promise in Large B-Cell Lymphoma Treatment - Stock Titan

Tue, 17 Jun 2025
Lyell Immunopharma Stock Soars 23.11% Post Reverse Split - AInvest

Wed, 04 Jun 2025
From Collapse to Comeback: Lyell Immunopharma's Stock Surge Signals Turning Point—Cancer Breakthrough? - FXLeaders

Wed, 04 Jun 2025
Lyell Immunopharma Showcases Next-Gen Cancer Therapies at Major Goldman Sachs Healthcare Event - Stock Titan

Wed, 04 Jun 2025
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 15 (M)
Held by Insiders 9.57e+006 (%)
Held by Institutions 11.7 (%)
Shares Short 485 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -2.014e+008
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -801 %
Return on Assets (ttm) 85.6 %
Return on Equity (ttm) -24.5 %
Qtrly Rev. Growth 65000 %
Gross Profit (p.s.) 0.33
Sales Per Share 0.19
EBITDA (p.s.) -0.76
Qtrly Earnings Growth -25 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -175 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales 47.84
Price to Cash Flow -0.11
Stock Dividends
Dividend 0
Forward Dividend 355340
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android